UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics
SHENZHEN, China, Aug. 29, 2024 /PRNewswire/ — UTime Limited (NASDAQ: WTO) (“UTime” or the “Company”), which continues to build on its strengths in the global healthcare sector, has announced that it has commenced a comprehensive… Read More »UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics



